NEW YORK, NY / ACCESS Newswire / March 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus ...
Atria Investments Inc bought a new position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) in the 4th quarter, HoldingsChannel.com reports. The fund bought 7,978 shares of the specialty ...
In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results